{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:17Z","timestamp":1790674097161,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melanoma is the deadliest form of skin cancer, and little is known about the impact of deregulated expression of long noncoding RNAs (lncRNAs) in the progression of this cancer. In this study, we explored RNA-Seq data to search for lncRNAs associated with melanoma progression. We found distinct lncRNA gene expression patterns across melanocytes, primary and metastatic melanoma cells. Also, we observed upregulation of the lncRNA <jats:italic>ZEB1-AS1<\/jats:italic> (ZEB1 antisense RNA 1) in melanoma cell lines. Data analysis from The Cancer Genome Atlas (TCGA) confirmed higher <jats:italic>ZEB1-AS1<\/jats:italic> expression in metastatic melanoma and its association with hotspot mutations in <jats:italic>BRAF<\/jats:italic> (B-Raf proto-oncogene, serine\/threonine kinase) gene and <jats:italic>RAS<\/jats:italic> family genes. In addition, a positive correlation between <jats:italic>ZEB1-AS1<\/jats:italic> and <jats:italic>ZEB1<\/jats:italic> (zinc finger E-box binding homeobox 1) gene expression was verified in primary and metastatic melanomas. Using gene expression signatures indicative of invasive or proliferative phenotypes, we found an association between <jats:italic>ZEB1-AS1<\/jats:italic> upregulation and a transcriptional profile for invasiveness. Enrichment analysis of correlated genes demonstrated cancer genes and pathways associated with <jats:italic>ZEB1-AS1<\/jats:italic>. We suggest that the lncRNA <jats:italic>ZEB1-AS1<\/jats:italic> could function by activating <jats:italic>ZEB1<\/jats:italic> gene expression, thereby influencing invasiveness and phenotype switching in melanoma, an epithelial-to-mesenchymal transition (EMT)-like process, which the <jats:italic>ZEB1<\/jats:italic> gene has an essential role.<\/jats:p>","DOI":"10.1038\/s41598-019-47363-6","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T10:02:59Z","timestamp":1564999379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma"],"prefix":"10.1038","volume":"9","author":[{"given":"\u00c1damo Davi Di\u00f3genes","family":"Siena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Rodrigues","family":"Pla\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Ferreira","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Ichihara","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Peronni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greice","family":"Molfetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos Alberto Oliveira","family":"de Biagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-4234","authenticated-orcid":false,"given":"Enilza Maria","family":"Espreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josane Freitas","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-2886","authenticated-orcid":false,"suffix":"Jr.","given":"Wilson Ara\u00fajo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"47363_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller, A. J. & Mihm, M. C. Melanoma. N. Engl. J. Med. 355, 51\u201365 (2006).","journal-title":"N. Engl. J. Med."},{"key":"47363_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA. Cancer J. Clin. 64, 9\u201329 (2014).","journal-title":"CA. Cancer J. Clin."},{"key":"47363_CR3","first-page":"572","volume":"7","author":"A Sandru","year":"2014","unstructured":"Sandru, A., Voinea, S., Panaitescu, E. & Blidaru, A. Survival rates of patients with metastatic malignant melanoma. J. Med. Life 7, 572\u20136 (2014).","journal-title":"J. Med. Life"},{"key":"47363_CR4","unstructured":"American Cancer Society. Cancer Facts & Figures (2014)."},{"key":"47363_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","volume":"20","author":"PV Dickson","year":"2011","unstructured":"Dickson, P. V. & Gershenwald, J. E. Staging and prognosis of cutaneous melanoma. Surg. Oncol. Clin. N. Am. 20, 1\u201317 (2011).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"47363_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10, 155\u2013159 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"47363_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nature10887","volume":"482","author":"M Guttman","year":"2012","unstructured":"Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339\u2013346 (2012).","journal-title":"Nature"},{"key":"47363_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904\u201314 (2011).","journal-title":"Mol. Cell"},{"key":"47363_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","volume":"15","author":"A Fatica","year":"2013","unstructured":"Fatica, A. & Bozzoni, I. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 15, 7\u201321 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"47363_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00109-014-1131-8","volume":"92","author":"PG Maass","year":"2014","unstructured":"Maass, P. G., Luft, F. C. & B\u00e4hring, S. Long non-coding RNA in health and disease. J. Mol. Med. (Berl). 92, 337\u201346 (2014).","journal-title":"J. Mol. Med. (Berl)."},{"key":"47363_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/2159-8290.CD-11-0209","volume":"1","author":"JR Prensner","year":"2011","unstructured":"Prensner, J. R. & Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391\u2013407 (2011).","journal-title":"Cancer Discov."},{"key":"47363_CR12","doi-asserted-by":"publisher","first-page":"e100893","DOI":"10.1371\/journal.pone.0100893","volume":"9","author":"R Li","year":"2014","unstructured":"Li, R. et al. Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation. PLoS One 9, e100893 (2014).","journal-title":"PLoS One"},{"key":"47363_CR13","doi-asserted-by":"publisher","first-page":"36711","DOI":"10.18632\/oncotarget.9164","volume":"7","author":"L Goedert","year":"2016","unstructured":"Goedert, L. et al. RMEL3, a novel BRAF&lt;sup&gt;V600E&lt;\/sup&gt;-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget 7, 36711\u201336718 (2016).","journal-title":"Oncotarget"},{"key":"47363_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0804-2","volume":"33","author":"Y Wei","year":"2016","unstructured":"Wei, Y. et al. LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0\/G1 cell cycle arrest in melanoma. Med. Oncol. 33, 88 (2016).","journal-title":"Med. Oncol."},{"key":"47363_CR15","first-page":"251098","volume":"2013","author":"L Tang","year":"2013","unstructured":"Tang, L., Zhang, W., Su, B. & Yu, B. Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed Res. Int. 2013, 251098 (2013).","journal-title":"Biomed Res. Int."},{"key":"47363_CR16","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.2147\/OTT.S98203","volume":"9","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth. in vivo. Onco. Targets. Ther. 9, 4075\u201387 (2016).","journal-title":"in vivo. Onco. Targets. Ther."},{"key":"47363_CR17","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1158\/0008-5472.CAN-10-4460","volume":"71","author":"D Khaitan","year":"2011","unstructured":"Khaitan, D. et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 71, 3852\u201362 (2011).","journal-title":"Cancer Res."},{"key":"47363_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature17161","volume":"531","author":"E Leucci","year":"2016","unstructured":"Leucci, E. et al. Melanoma addiction to the long non-coding RNA SAMMSON. Nature 531, 518\u2013522 (2016).","journal-title":"Nature"},{"key":"47363_CR19","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/stem.1547","volume":"31","author":"C P\u00e1dua Alves","year":"2013","unstructured":"P\u00e1dua Alves, C. et al. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 31, 2827\u201332 (2013).","journal-title":"Stem Cells"},{"key":"47363_CR20","doi-asserted-by":"publisher","first-page":"e40378","DOI":"10.1371\/journal.pone.0040378","volume":"7","author":"N Fenouille","year":"2012","unstructured":"Fenouille, N. et al. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. PLoS One 7, e40378 (2012).","journal-title":"PLoS One"},{"key":"47363_CR21","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"Larue, L. & Bellacosa, A. Epithelial\u2013mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2032 kinase\/AKT pathways. Oncogene 24, 7443\u20137454 (2005).","journal-title":"Oncogene"},{"key":"47363_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek, K. S. et al. In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States. Cancer Res. 68, 650\u2013656 (2008).","journal-title":"Cancer Res."},{"key":"47363_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1755-148X.2010.00757.x","volume":"23","author":"KS Hoek","year":"2010","unstructured":"Hoek, K. S. & Goding, C. R. Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746\u2013759 (2010).","journal-title":"Pigment Cell Melanoma Res."},{"key":"47363_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1600-0749.2006.00322.x","volume":"19","author":"KS Hoek","year":"2006","unstructured":"Hoek, K. S. et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290\u2013302 (2006).","journal-title":"Pigment Cell Res."},{"key":"47363_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ncb2535","volume":"14","author":"O Shakhova","year":"2012","unstructured":"Shakhova, O. et al. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat. Cell Biol. 14, 882\u2013890 (2012).","journal-title":"Nat. Cell Biol."},{"key":"47363_CR26","first-page":"823","volume":"61","author":"FA Scholl","year":"2001","unstructured":"Scholl, F. A. et al. PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61, 823\u20136 (2001).","journal-title":"Cancer Res."},{"key":"47363_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel, J. et al. A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma. Cancer Cell 24, 466\u2013480 (2013).","journal-title":"Cancer Cell"},{"key":"47363_CR28","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/jid.2011.142","volume":"131","author":"C Wels","year":"2011","unstructured":"Wels, C., Joshi, S., Koefinger, P., Bergler, H. & Schaider, H. Transcriptional Activation of ZEB1 by Slug Leads to Cooperative Regulation of the Epithelial\u2013Mesenchymal Transition-Like Phenotype in Melanoma. J. Invest. Dermatol. 131, 1877\u20131885 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"47363_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7683","volume":"6","author":"A Verfaillie","year":"2015","unstructured":"Verfaillie, A. et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat. Commun. 6, 6683 (2015).","journal-title":"Nat. Commun."},{"key":"47363_CR30","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1073\/pnas.1303491110","volume":"110","author":"JS Pawlikowski","year":"2013","unstructured":"Pawlikowski, J. S. et al. Wnt signaling potentiates nevogenesis. Proc. Natl. Acad. Sci. USA 110, 16009\u201314 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"47363_CR31","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1101\/gr.124321.111","volume":"21","author":"S Tarazona","year":"2011","unstructured":"Tarazona, S., Garc\u00eda-Alcalde, F., Dopazo, J., Ferrer, A. & Conesa, A. Differential expression in RNA-seq: a matter of depth. Genome Res. 21, 2213\u201323 (2011).","journal-title":"Genome Res."},{"key":"47363_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0458-2","volume":"14","author":"E Raveh","year":"2015","unstructured":"Raveh, E., Matouk, I. J., Gilon, M. & Hochberg, A. The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory. Mol. Cancer 14, 184 (2015).","journal-title":"Mol. Cancer"},{"key":"47363_CR33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u20135 (2013).","journal-title":"Nat. Genet."},{"key":"47363_CR34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"R Akbani","year":"2015","unstructured":"Akbani, R. et al. Genomic Classification of Cutaneous Melanoma. Cell 161, 1681\u20131696 (2015).","journal-title":"Cell"},{"key":"47363_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fonc.2015.00031","volume":"5","author":"FZ Li","year":"2015","unstructured":"Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G. & Ferrao, P. T. Phenotype switching in melanoma: implications for progression and therapy. Front. Oncol. 5, 31 (2015).","journal-title":"Front. Oncol."},{"key":"47363_CR36","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte, M. The emerging role of lncRNAs in cancer. Nat Med 21, 1253\u20131261 (2015).","journal-title":"Nat Med"},{"key":"47363_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-38","volume":"10","author":"EA Gibb","year":"2011","unstructured":"Gibb, E. A., Brown, C. J. & Lam, W. L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 10, 38 (2011).","journal-title":"Mol. Cancer"},{"key":"47363_CR38","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775\u201389 (2012).","journal-title":"Genome Res."},{"key":"47363_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00856-8","volume":"7","author":"S Li","year":"2017","unstructured":"Li, S. et al. Exploring functions of long noncoding RNAs across multiple cancers through co-expression network. Sci. Rep. 7, 754 (2017).","journal-title":"Sci. Rep."},{"key":"47363_CR40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ng.3637","volume":"48","author":"H Guo","year":"2016","unstructured":"Guo, H. et al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nat. Genet. 48, 1142\u20131150 (2016).","journal-title":"Nat. Genet."},{"key":"47363_CR41","doi-asserted-by":"publisher","first-page":"e12423","DOI":"10.1111\/cpr.12423","volume":"51","author":"J Li","year":"2018","unstructured":"Li, J. et al. ZEB1-AS1: A crucial cancer-related long non-coding RNA. Cell Prolif. 51, e12423 (2018).","journal-title":"Cell Prolif."},{"key":"47363_CR42","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/onc.2015.223","volume":"35","author":"T Li","year":"2016","unstructured":"Li, T. et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene 35, 1575\u20131584 (2016).","journal-title":"Oncogene"},{"key":"47363_CR43","first-page":"4095","volume":"8","author":"C Liu","year":"2016","unstructured":"Liu, C. & Lin, J. Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. Am. J. Transl. Res. 8, 4095\u20134105 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"47363_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0711-y","volume":"16","author":"W Su","year":"2017","unstructured":"Su, W. et al. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer. Mol. Cancer 16, 142 (2017).","journal-title":"Mol. Cancer"},{"key":"47363_CR45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature11071","volume":"485","author":"MF Berger","year":"2012","unstructured":"Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502\u20136 (2012).","journal-title":"Nature"},{"key":"47363_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251\u201363 (2012).","journal-title":"Cell"},{"key":"47363_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00606-w","volume":"7","author":"B de Unamuno Bustos","year":"2017","unstructured":"de Unamuno Bustos, B. et al. Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel. Sci. Rep. 7, 495 (2017).","journal-title":"Sci. Rep."},{"key":"47363_CR48","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.15252\/emmm.201505971","volume":"8","author":"G Richard","year":"2016","unstructured":"Richard, G. et al. ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors. EMBO Mol. Med. 8, 1143\u20131161 (2016).","journal-title":"EMBO Mol. Med."},{"key":"47363_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1755-148X.2012.00986.x","volume":"25","author":"DS Widmer","year":"2012","unstructured":"Widmer, D. S. et al. Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res. 25, 343\u2013353 (2012).","journal-title":"Pigment Cell Melanoma Res."},{"key":"47363_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","volume":"12","author":"C Levy","year":"2006","unstructured":"Levy, C., Khaled, M. & Fisher, D. E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406\u2013414 (2006).","journal-title":"Trends Mol. Med."},{"key":"47363_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ccr.2004.10.014","volume":"6","author":"J Du","year":"2004","unstructured":"Du, J. et al. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6, 565\u2013576 (2004).","journal-title":"Cancer Cell"},{"key":"47363_CR52","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1101\/gad.406406","volume":"20","author":"S Carreira","year":"2006","unstructured":"Carreira, S. et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426\u201339 (2006).","journal-title":"Genes Dev."},{"key":"47363_CR53","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1349-7006.2009.01266.x","volume":"100","author":"K Kido","year":"2009","unstructured":"Kido, K. et al. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation. Cancer Sci. 100, 1863\u20131869 (2009).","journal-title":"Cancer Sci."},{"key":"47363_CR54","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1158\/1078-0432.CCR-12-2675","volume":"19","author":"E Sanchez-Tillo","year":"2013","unstructured":"Sanchez-Tillo, E. et al. ZEB1 Promotes Invasiveness of Colorectal Carcinoma Cells through the Opposing Regulation of uPA and PAI-1. Clin. Cancer Res. 19, 1071\u20131082 (2013).","journal-title":"Clin. Cancer Res."},{"key":"47363_CR55","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1172\/JCI76725","volume":"126","author":"JE Larsen","year":"2016","unstructured":"Larsen, J. E. et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J. Clin. Invest. 126, 3219\u20133235 (2016).","journal-title":"J. Clin. Invest."},{"key":"47363_CR56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","volume":"14","author":"P Zhang","year":"2015","unstructured":"Zhang, P., Sun, Y. & Ma, L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 14, 481\u20137 (2015).","journal-title":"Cell Cycle"},{"key":"47363_CR57","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/jcb.25203","volume":"116","author":"T Eguchi","year":"2015","unstructured":"Eguchi, T., Prince, T., Wegiel, B. & Calderwood, S. K. Role and Regulation of Myeloid Zinc Finger Protein 1 in Cancer. J. Cell. Biochem. 116, 2146\u20132154 (2015).","journal-title":"J. Cell. Biochem."},{"key":"47363_CR58","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2017.06.015","volume":"403","author":"Y-K Lee","year":"2017","unstructured":"Lee, Y.-K. et al. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells. Cancer Lett. 403, 144\u2013151 (2017).","journal-title":"Cancer Lett."},{"key":"47363_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2018.06.001","volume":"34","author":"D Zingg","year":"2018","unstructured":"Zingg, D. et al. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation. Cancer Cell 34, 69\u201384.e14 (2018).","journal-title":"Cancer Cell"},{"key":"47363_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13630-016-0027-3","volume":"5","author":"M Cao","year":"2015","unstructured":"Cao, M. & Zhong, Q. Cilia in autophagy and cancer. Cilia 5, 4 (2015).","journal-title":"Cilia"},{"key":"47363_CR61","doi-asserted-by":"publisher","first-page":"E10532","DOI":"10.1073\/pnas.1711534114","volume":"114","author":"VJ Guen","year":"2017","unstructured":"Guen, V. J. et al. EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling. Proc. Natl. Acad. Sci. 114, E10532\u2013E10539 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"47363_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14422","volume":"8","author":"P Koirala","year":"2017","unstructured":"Koirala, P. et al. LncRNA AK023948 is a positive regulator of AKT. Nat. Commun. 8, 14422 (2017).","journal-title":"Nat. Commun."},{"key":"47363_CR63","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/nar\/gkw047","volume":"44","author":"X Zong","year":"2016","unstructured":"Zong, X. et al. Natural antisense RNA promotes 3\u2032 end processing and maturation of MALAT1 lncRNA. Nucleic Acids Res. 44, 2898\u20132908 (2016).","journal-title":"Nucleic Acids Res."},{"key":"47363_CR64","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M. & Chang, H. Y. Long Noncoding RNAs in Cancer Pathways. Cancer Cell 29, 452\u2013463 (2016).","journal-title":"Cancer Cell"},{"key":"47363_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-19","volume":"8","author":"JF Sousa","year":"2008","unstructured":"Sousa, J. F. & Espreafico, E. M. Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets. BMC Cancer 8, 19 (2008).","journal-title":"BMC Cancer"},{"key":"47363_CR66","doi-asserted-by":"publisher","first-page":"e13510","DOI":"10.1371\/journal.pone.0013510","volume":"5","author":"JF Sousa","year":"2010","unstructured":"Sousa, J. F. et al. Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool. PLoS One 5, e13510 (2010).","journal-title":"PLoS One"},{"key":"47363_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31170-6","volume":"8","author":"LF Araujo","year":"2018","unstructured":"Araujo, L. F. et al. Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma. Sci. Rep. 8, 14190 (2018).","journal-title":"Sci. Rep."},{"key":"47363_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"47363_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"47363_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u201312 (2009).","journal-title":"Nature"},{"key":"47363_CR71","doi-asserted-by":"publisher","first-page":"W741","DOI":"10.1093\/nar\/gki475","volume":"33","author":"B Zhang","year":"2005","unstructured":"Zhang, B., Kirov, S. & Snoddy, J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33, W741\u2013W748 (2005).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47363-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:15:41Z","timestamp":1671279341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47363-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47363"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47363-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11350"}}